<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958866</url>
  </required_header>
  <id_info>
    <org_study_id>0156</org_study_id>
    <nct_id>NCT01958866</nct_id>
  </id_info>
  <brief_title>Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen.

      This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product
      compared with the acetaminophen. Total of 96 patients with body temperature between 37.8-38.5
      without any signs of infections will be enrolled in this study. Patients will be randomly
      divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr, Second
      group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third group
      will receive placebo twice daily.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in each group will be monitored for body temperature at baseline (at the time of
      enrollment) and at 1, 2, 4, 6, 8, 24 h after receiving the tested material.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Temperature</measure>
    <time_frame>Change from baseline in temperature at 1, 2, 3, 4, 6, 8, 12 and 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events: diarrhea, elevated liver enzyme and elevated creatinine</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (24 hours)</time_frame>
    <description>Liver and kidney function will be randomly evaluated. Number of participants with soft stool will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Patients With Body Temperature Between 37.8-38.5</condition>
  <condition>No Sign of Infection</condition>
  <condition>No Liver and Kidney Problem</condition>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acetaminophen administer 1000 mg every 4-6 hours when fever is presented</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tinospora Crispa-extract Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tinospora Crispa-extract tablet administer 500 mg every 4-6 hours when fever is presented</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 2 tablets will be administered every 4 hours when fever is presented</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tinospora Crispa-extract Product</intervention_name>
    <arm_group_label>Tinospora Crispa-extract Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <arm_group_label>Acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old

          -  Body temperature between 37.8-38.5

          -  Body weight not less than 40 kg but not over 100 kg

          -  Liver enzymes do not exceed 2 times of normal value

          -  Can comply with study protocol

        Exclusion Criteria:

          -  Have allergic history of any tested compounds

          -  Fever from other causes, not by URI

          -  Take any herbal medicines during 2 weeks before enrollment

          -  Physicians decide to withdraw the subjects with any reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pornanong Aramwit</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Pornanong Aramwit, Pharm.D., Ph.D</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Fever</keyword>
  <keyword>Body temperature</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

